Painreform Stock Investor Sentiment

PRFX Stock  USD 2.85  0.12  4.04%   
Slightly above 61% of Painreform's investor base is looking to short. The analysis of the overall investor sentiment regarding Painreform suggests that many traders are alarmed. Painreform's investing sentiment can be driven by a variety of factors including economic data, Painreform's earnings reports, geopolitical events, and overall market trends.
  

Painreform Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Painreform can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at benzinga.com         
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Success...
benzinga news
over three months ago at news.google.com         
PainReform Announces Crucial Shareholders Meeting - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
PainReform Given Buy Rating at Maxim Group - Defense World
Google News at Macroaxis
over three months ago at benzinga.com         
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
benzinga news
over three months ago at news.google.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Friday - InvestorPlace
Google News at Macroaxis
over three months ago at news.google.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Thursday - InvestorPlace
Google News at Macroaxis
over three months ago at finance.yahoo.com         
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
Yahoo News
over three months ago at seekingalpha.com         
PainReform receives Nasdaq minimum bid price notification
seekingalpha News
over three months ago at investing.com         
PainReform faces Nasdaq delisting over share price
Investing News at Macroaxis
over six months ago at investorplace.com         
PRFX Stock Earnings PainReform Misses EPS for Q1 2024
sbwire news
over six months ago at seekingalpha.com         
PainReform reports Q1 results
seekingalpha News
over six months ago at finance.yahoo.com         
PainReform Provides Business Update for the First Quarter of 2024
Yahoo News
over six months ago at finance.yahoo.com         
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help...
Yahoo News
over six months ago at news.google.com         
Short Interest in PainReform Ltd. Increases By 232.9 percent - Defense World
Google News at Macroaxis
over six months ago at globenewswire.com         
PainReform Announces Closing of 4 Million Public Offering
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Painreform that are available to investors today. That information is available publicly through Painreform media outlets and privately through word of mouth or via Painreform internal channels. However, regardless of the origin, that massive amount of Painreform data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Painreform news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Painreform relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Painreform's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Painreform alpha.

Painreform Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
PainReform Shares Are Trading Lower Today Whats Going On
09/10/2024
2
US Stocks Edge Higher Chicago Fed National Activity Increases In August
09/23/2024
3
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders Equity Requirement
11/07/2024
4
PainReform Stock Is Soaring Tuesday Whats Going On
11/19/2024
5
US Stocks Mostly Lower Target Posts Downbeat Earnings
11/20/2024

Additional Tools for Painreform Stock Analysis

When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.